StockNews com Begins Coverage on InVivo Therapeutics (NASDAQ:NVIV) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Equities research analysts at StockNews.com started coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance InVivo Therapeutics has a 12-month low of $0.22 and a 12-month high of $2.40. The […]
StockNews.com assumed coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance InVivo Therapeutics has a 52 week low of $0.22 and a 52 week high of $2.40. […]
Discover the latest developments in the spine and orthopedic medtech industry, including bankruptcies, closures, layoffs, and successes for top companies.